References
- Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-ralated disorders. Ann Rheum Dis. 2009;68(8):1310–5.
- Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al;Sjögren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's international Collaborative Clinical Alliance cohort. Arthritis Care Res. 2012;64(4):475–87.
- Trimarchi C, La Sala D, Zamparelli A, Cinti C. Detection of apoptotic deoxyribonucleic acid break by in situ nick translation. Methods Mol Biol. 2004;285:113–8.
- Takagi Y, Kimura Y, Nakamura H, Sasaki M, Eguchi K, Nakamura T. Salivary gland ultrasonography: can it be an alternative to sialography as an imaging modality for Sjögren's syndrome?Ann Rheum Dis. 2010;69(7):1321–4.
- Shimizu M, Moriyama M, Okamura K, Kawazu T, Chikui T, Goto T, et al. Sonographic diagnosis for Mikulicz disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(1):105–13.
- Ohlsson M, Jonsson R, Brokstad KA. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apotosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol. 2002; 56(5):456–69.
- Barcellos KS, Nonogaki S, Enokihara MM, Teixeira MS, Andrade LE. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome. J Rheumatol. 2007; 34(6):1283–92.
- Baer AN, Gourin CG, Westra WH, Cox DP, Greenspan JS, Daniels TE;Sjögren's International Collaborative Alliance. Rare diagnosis of IgG4-related systemic disease by lip biopsy in an international Sjögren syndrome registry. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(3):e34–9.
- Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al;Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1–14.
- Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD),2011. Mod Rheumatol.2012; 22(1):21–30.
- Tsubota K, Fujita H, Tsuzaka K, Takeuchi T. Mikulicz's disease and Sjögren's syndrome. Invest Ophthalmol Vis Sci. 2000;41(7): 1666–73.
- Tsuzaka K, Matsumoto Y, Sasaki Y, Abe T, Tsubota K, Takeuchi T. Down-regulation of Fas-ligand mRNA in Sjögren's syndrome patients with enlarged exocrine glands. Autoimmunity. 2007;40(7): 497–502.
- Tsubota K, Fujita H, Tadano K, Onoda N, Tsuzaka K, Takeuchi T. Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjögren's syndrome patients with enlarged exocrine glands. Clin Exp Immunol. 2002;129(1):177–82.
- Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome. Transl Res. 2006;148(6): 281–8.